ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,675 | -71.2% | 9,376 | -59.8% | 0.00% | – |
| Q2 2023 | $606,347 | +5.8% | 23,339 | +17.0% | 0.00% | – |
| Q1 2023 | $572,849 | -22.3% | 19,946 | -19.9% | 0.00% | – |
| Q4 2022 | $737,336 | +438.2% | 24,910 | +330.9% | 0.00% | – |
| Q3 2022 | $137,000 | +24.5% | 5,781 | +16.6% | 0.00% | – |
| Q2 2022 | $110,000 | -85.0% | 4,956 | -83.0% | 0.00% | – |
| Q1 2022 | $732,000 | -31.3% | 29,163 | -2.1% | 0.00% | – |
| Q4 2021 | $1,066,000 | +22.5% | 29,776 | +45.7% | 0.00% | – |
| Q3 2021 | $870,000 | +98.6% | 20,437 | +102.0% | 0.00% | – |
| Q2 2021 | $438,000 | -45.1% | 10,115 | -48.3% | 0.00% | – |
| Q1 2021 | $798,000 | +1673.3% | 19,565 | +1884.3% | 0.00% | – |
| Q4 2020 | $45,000 | -40.0% | 986 | -53.3% | 0.00% | – |
| Q3 2020 | $75,000 | +70.5% | 2,113 | +79.8% | 0.00% | – |
| Q2 2020 | $44,000 | -78.0% | 1,175 | -83.0% | 0.00% | – |
| Q1 2020 | $200,000 | +2.6% | 6,916 | +83.9% | 0.00% | – |
| Q4 2019 | $195,000 | -90.5% | 3,760 | -89.9% | 0.00% | -100.0% |
| Q3 2019 | $2,046,000 | +173.9% | 37,284 | +102.9% | 0.00% | – |
| Q2 2019 | $747,000 | -77.4% | 18,375 | -83.2% | 0.00% | -100.0% |
| Q1 2019 | $3,300,000 | +37.4% | 109,132 | +52.7% | 0.00% | 0.0% |
| Q4 2018 | $2,402,000 | -9.4% | 71,470 | +13.7% | 0.00% | 0.0% |
| Q3 2018 | $2,651,000 | +58.9% | 62,854 | +20.6% | 0.00% | 0.0% |
| Q2 2018 | $1,668,000 | +983.1% | 52,119 | +1585.1% | 0.00% | – |
| Q1 2018 | $154,000 | -39.8% | 3,093 | -34.9% | 0.00% | – |
| Q4 2017 | $256,000 | +73.0% | 4,753 | +85.4% | 0.00% | – |
| Q3 2017 | $148,000 | +66.3% | 2,564 | +41.9% | 0.00% | – |
| Q2 2017 | $89,000 | +18.7% | 1,807 | +5.0% | 0.00% | – |
| Q1 2017 | $75,000 | -48.3% | 1,721 | -41.8% | 0.00% | – |
| Q4 2016 | $145,000 | +2.1% | 2,959 | -0.4% | 0.00% | – |
| Q3 2016 | $142,000 | +30.3% | 2,971 | +45.0% | 0.00% | – |
| Q2 2016 | $109,000 | -85.3% | 2,049 | -87.7% | 0.00% | – |
| Q1 2016 | $744,000 | +1081.0% | 16,636 | +896.8% | 0.00% | – |
| Q4 2015 | $63,000 | -23.2% | 1,669 | -34.4% | 0.00% | – |
| Q3 2015 | $82,000 | +17.1% | 2,544 | +19.5% | 0.00% | – |
| Q2 2015 | $70,000 | -89.1% | 2,129 | -86.4% | 0.00% | – |
| Q1 2015 | $642,000 | -37.1% | 15,609 | -37.7% | 0.00% | -100.0% |
| Q4 2014 | $1,021,000 | – | 25,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |